Diversified Healthcare Trust (DHCNL) Cash & Equivalents (2009 - 2026)

Diversified Healthcare Trust has reported Cash & Equivalents for 18 years, with the latest figure at $121.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 59.75% year-over-year to $121.8 million; the trailing twelve-month figure through Mar 2026 stood at $121.8 million (down 59.75% YoY), and the FY2025 full-year result was $105.4 million, down 27.1% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $121.8 million, up from $105.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $732.1 million in Q1 2022, with the low at $105.4 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $339.7 million across 5 years, with a median of $265.6 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 62.63% — and 2025, when it surged 46.09%.
• Diversified Healthcare Trust's Cash & Equivalents stood at $658.1 million in 2022, then plunged by 62.63% to $245.9 million in 2023, then plunged by 41.21% to $144.6 million in 2024, then slipped by 27.1% to $105.4 million in 2025, then rose by 15.53% to $121.8 million in 2026.
• The last three Cash & Equivalents figures came in at $121.8 million (Q1 2026), $105.4 million (Q4 2025), and $201.4 million (Q3 2025), per Business Quant data.